Institutional Manager · CIK 0001515070
TFG Asset Management GP Ltd
Grand Cayman, E9 · File #028-15287
Latest AUM
$474.3M
Positions
31
Top-10 Concentration
82.6%
Filings
10
Portfolio Value Over Time
2024-03
2024-06
2024-09
2024-12
2025-03
2025-06
2025-09
2025-12
Biggest QoQ Changes
Ranked by conviction flow (share change × current price) so mark-to-market moves don't dominate. Price effect column shows how much of the $ change was just the stock moving.
| Action | Issuer | Ticker / CUSIP | Δ Shares | Flow ($) | Price Effect |
|---|---|---|---|---|---|
| EXITED | ALIBABA GROUP HLDG LTD | 01609WBG6 | -95,000,000 | -$174.8M | $0 |
| REDUCE | UIPATH INC | PATH | -7,082,044 | -$116.1M | +$29.9M |
| EXITED | ISHARES TR | 464288513 | -726,900 | -$59.0M | $0 |
| EXITED | LITHIUM ARGENTINA AG | 53680QAA6 | -27,109,000 | -$24.6M | $0 |
| EXITED | CABLE ONE INC | 12685JAE5 | -21,255,000 | -$20.8M | $0 |
| EXITED | PROGRESS SOFTWARE CORP | 743312AB6 | -20,500,000 | -$20.6M | $0 |
| EXITED | OATLY GROUP AB | 67421JAC2 | -20,020,027 | -$18.4M | $0 |
| EXITED | FIRST MAJESTIC SILVER CORP | 32076VAD5 | -7,500,000 | -$8.0M | $0 |
| EXITED | CELCUITY INC | 15102KAA8 | -5,550,000 | -$7.4M | $0 |
| EXITED | TARSUS PHARMACEUTICALS INC | 87650L103 | -125,000 | -$7.4M | $0 |
Sector Allocation
Filing History
- 13F HOLDINGS REPORTQ/E Dec 202531 pos · $474.3M
- 13F HOLDINGS REPORTQ/E Sep 202547 pos · $747.6M
- 13F HOLDINGS REPORTQ/E Jun 202540 pos · $620.8M
- 13F HOLDINGS REPORTQ/E Mar 202532 pos · $438.2M
- 13F HOLDINGS REPORT (Amended)Q/E Dec 202428 pos · $391.4M
- 13F HOLDINGS REPORTQ/E Dec 202428 pos · $405.6M
- 13F HOLDINGS REPORTQ/E Sep 202426 pos · $354.5M
- 13F HOLDINGS REPORTQ/E Jun 202430 pos · $400.9M
- 13F HOLDINGS REPORTQ/E Mar 202432 pos · $441.5M
- 13F HOLDINGS REPORTQ/E Dec 202350 pos · $548.3M
Top 20 Holdings — Dec 2025
| # | Issuer | Ticker | Shares | Value | % of Portfolio |
|---|---|---|---|---|---|
| 1 | UIPATH INC | PATH | 10,450,000 | $171.3M | 36.11% |
| 2 | UIPATH INC | PATH | 4,132,044 | $67.7M | 14.28% |
| 3 | UIPATH INC | PATH | 2,867,956 | $47.0M | 9.91% |
| 4 | LYFT INC | LYFT | 1,000,000 | $19.4M | 4.08% |
| 5 | AUTOLUS THERAPEUTICS PLC | AUTL | 9,500,000 | $18.9M | 3.99% |
| 6 | SPRINKLR INC | CXM | 2,200,000 | $17.1M | 3.61% |
| 7 | KOLIBRI GLOBAL ENERGY INC | KGEI | 4,254,954 | $16.7M | 3.53% |
| 8 | WORKIVA INC | WK | 150,000 | $12.9M | 2.73% |
| 9 | KOLIBRI GLOBAL ENERGY INC | KGEI | 2,679,550 | $10.5M | 2.22% |
| 10 | ANNEXON INC | ANNX | 2,032,455 | $10.2M | 2.15% |
| 11 | PRAXIS PRECISION MEDICINES I | PRAX | 22,952 | $6.8M | 1.43% |
| 12 | CELLDEX THERAPEUTICS INC NEW | CLDX | 243,800 | $6.6M | 1.40% |
| 13 | ARROWHEAD PHARMACEUTICALS IN | ARWR | 96,935 | $6.4M | 1.36% |
| 14 | PHARVARIS N V | PHVS | 194,612 | $5.4M | 1.14% |
| 15 | AXSOME THERAPEUTICS INC | AXSM | 26,934 | $4.9M | 1.04% |
| 16 | DYNE THERAPEUTICS INC | DYN | 247,997 | $4.9M | 1.02% |
| 17 | MBX BIOSCIENCES INC | MBX | 143,327 | $4.5M | 0.95% |
| 18 | RAPT THERAPEUTICS INC | 75382E208 | 131,770 | $4.5M | 0.94% |
| 19 | AGIOS PHARMACEUTICALS INC | AGIO | 162,018 | $4.4M | 0.93% |
| 20 | IMMUNOVANT INC | IMVT | 166,187 | $4.2M | 0.89% |